Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Queensland Health
Moodys
Daiichi Sankyo
AstraZeneca
Deloitte
Novartis
US Department of Justice
Harvard Business School
Merck
Boehringer Ingelheim

Generated: February 25, 2018

DrugPatentWatch Database Preview

Details for New Drug Application (NDA): 019518

« Back to Dashboard

NDA 019518 describes EXTRA-STRENGTH AIM, which is a drug marketed by Chesebrough Ponds and is included in one NDA. Additional details are available on the EXTRA-STRENGTH AIM profile page.

The generic ingredient in EXTRA-STRENGTH AIM is sodium monofluorophosphate. There are one thousand four hundred and fifteen drug master file entries for this compound. Additional details are available on the sodium monofluorophosphate profile page.
Summary for 019518
Tradename:EXTRA-STRENGTH AIM
Applicant:Chesebrough Ponds
Ingredient:sodium monofluorophosphate
Patents:0
Formulation / Manufacturing:see details

Profile for product number 001

Active Rx/OTC/Discontinued:DISCNDosage:PASTE;DENTALStrength1.2%
Approval Date:Jun 3, 1987TE:RLD:No

Profile for product number 002

Active Rx/OTC/Discontinued:DISCNDosage:GEL;DENTALStrength1.2%
Approval Date:Aug 6, 1986TE:RLD:No

Complete Access Available with Subscription

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Boehringer Ingelheim
Julphar
Daiichi Sankyo
Argus Health
US Army
Medtronic
Accenture
Cipla
Baxter

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

botpot